| Old Articles: <Older 4001-4010 Newer> |
|---|
 |
Pharmaceutical Executive
December 1, 2011
William Looney |
RaQualia's New Spin on the Startup We talk with Japanese CEO Atsushi Nagahisa to explore how culture can maximize the value of an inherited portfolio.   |
Pharmaceutical Executive
December 1, 2011
George Baeder |
China's Future in Bioscience Will big investments in infrastructure carry the day in positioning China as a global drug innovation powerhouse? |
The Motley Fool
December 13, 2011
Rick Aristotle Munarriz |
Renren: A Year in Review The Chinese social networking had a rough first year as a public company. |
The Motley Fool
December 12, 2011
Dan Newman |
Which Country Defaults Next? Japan's changing demographics might spell trouble for its high debt and low return bonds. |
The Motley Fool
December 12, 2011
Rebecca Lipman |
China's Landing: Will These Stocks Buck the Trend? Is China cooling more quickly than expected? |
The Motley Fool
December 8, 2011
Sean Williams |
Would You Take Advantage of This 30% Arbitrage Opportunity? Is a CEO departure and a lowered earnings outlook enough for you to leave 30% on the table? |
The Motley Fool
December 7, 2011
Jordan DiPietro |
Stay Away From These 3 Solar Companies Regulation makes the future too uncertain for these three Chinese companies: Yingli Green Energy... Suntech Power... Trina Solar... |
The Motley Fool
December 7, 2011
Rick Aristotle Munarriz |
More Stamps in IMAX's Passport The big screen leader inks deals in China and Indonesia. |
The Motley Fool
December 6, 2011
Amitabha Chakraborty |
Eni Expands Down Under Eni increases its acreage in Australian natural gas fields. |
The Motley Fool
December 5, 2011
Amanda Buchanan |
Royal Caribbean's Advantage With support from both the government and local businesses, Royal Caribbean is well positioned for growth in China. |
| <Older 4001-4010 Newer> Return to current articles. |
